EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of Ethanol and Opioid Receptor Antagonists Naltrexone and LY2444296 on the Organization of Cholesterol- and Sphingomyelin-Enriched Plasma Membrane Domains

Sho Oasa iD, Wai H Mak, Adam L Maddox, Carinna Lima, Andras Saftics, Lars Terenius iD, Tijana Jovanović-Talisman iD, Vladana Vukojević iD

ACS Chemical Neuroscience · 2025

DOI: 10.1021/acschemneuro.5c00596 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Sho Oasa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center of Molecular Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm 17176, Sweden. Hauptthemen laut MEDLINE: Naltrexone, Narcotic Antagonists, Ethanol, Cholesterol. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAAA NIH HHS, Vetenskapsrådet, Magnus Bergvalls Stiftelse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NaltrexoneNarcotic AntagonistsEthanolCholesterolSphingomyelinsCell MembraneMembrane MicrodomainsHumansAnimalsReceptors, Opioid

Stichwörter der Autor:innen

LY2444296cholesterol/sphingomyelin domainsethanolfluorescence correlation spectroscopy (FCS)naltrexonesingle-molecule localization microscopy (SMLM)

Substanzen

NaltrexoneNarcotic AntagonistsEthanolCholesterolSphingomyelinsReceptors, Opioid

Autor:innen und Institutionen

  • Center of Molecular Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm 17176, Sweden.
  • Department of Cancer Biology & Molecular Medicine, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, California 91010, United States.

ORCID-Profile: Sho Oasa, Lars Terenius, Tijana Jovanović-Talisman, Vladana Vukojević

Förderung

  • NIAAA NIH HHS
  • Vetenskapsrådet
  • Magnus Bergvalls Stiftelse
  • National Institute on Alcohol Abuse and Alcoholism
  • Karolinska Institutet

Zitieren

APA

Oasa, S., Mak, W. H., Maddox, A. L., Lima, C., Saftics, A., Terenius, L., Jovanović-Talisman, T., & Vukojević, V. (2025). Effects of Ethanol and Opioid Receptor Antagonists Naltrexone and LY2444296 on the Organization of Cholesterol- and Sphingomyelin-Enriched Plasma Membrane Domains. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.5c00596

Vancouver

Oasa S, Mak WH, Maddox AL, Lima C, Saftics A, Terenius L, et al. Effects of Ethanol and Opioid Receptor Antagonists Naltrexone and LY2444296 on the Organization of Cholesterol- and Sphingomyelin-Enriched Plasma Membrane Domains. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00596

BibTeX
@article{Oasa2025,
  author = {Oasa, Sho and Mak, Wai H and Maddox, Adam L and Lima, Carinna and Saftics, Andras and Terenius, Lars and Jovanović-Talisman, Tijana and Vukojević, Vladana},
  title = {Effects of Ethanol and Opioid Receptor Antagonists Naltrexone and LY2444296 on the Organization of Cholesterol- and Sphingomyelin-Enriched Plasma Membrane Domains},
  journal = {ACS Chemical Neuroscience},
  year = {2025},
  doi = {10.1021/acschemneuro.5c00596}
}
Kostenlos starten →